Under the brand name "Avicenna"

Today, the pharmaceutical industry of Uzbekistan concerns to dynamically developing sectors of the national economy. This is due to the fact that the state policy and strategy development of the industry aimed at stimulating the growth of productive capacity to attract foreign investment by providing a system of privileges and preferences.

In accordance with the presidential decree "On additional measures to stimulate foreign direct investment" from April 10, 2012 the enterprise sectors of the economy, including the production of medicines, attracting direct private foreign investments are exempt from paying taxes on profits, property, landscaping and development of social infrastructure, single tax payment for micro and small enterprises, compulsory contributions to the Republican Road Fund for a period of three to seven years, depending on the volume of investments.

However, the national legislation provides domestic pharmaceutical manufacturers privilege to participate in international tenders for the purchase of medicines and drugs on government contracts, and therefore an important condition for the speedy development of the Uzbek market of drugs in the country seems to create a joint venture.

In regions of the country the production of pharmaceuticals and medical products company engaged with the appropriate licenses. An active participant on market of Navoi region over the last decade remains "Avicenna" Ltd. under JSC "Dori-Darmon Navoi". In the nomenclature of small business eight names of licensed medicines which’s used by local health care facilities and pharmacy chain, as well as consumers of neighboring areas.

Having established itself as a dynamically developing modern enterprise, "Avicenna" annually expands product range of sold drugs primarily for external use with a wide range of pharmacological action.

Since the release of the first drugs small business actively develops and heavily invests into the modernization of production to meet the standards of quality and production conditions. According to the JSC "Dori-Darmon Navoi", production of quality, safe and efficient production of "Avicenna" guaranteed quality certificate ISO-9001-2008 national standard. This has enabled the company to enter other regional markets and increase the portfolio of orders.

Manufacturers of drugs of Uzbekistan successfully cooperate with the leading companies in the world. Investment attractiveness of the pharmaceutical sector in the country provides enough sales market, the simplified mechanism of export products produced here, as well as the opportunity to enter the markets of neighboring countries.

IA "Jahon"